1. Home
  2. ARWR vs AY Comparison

ARWR vs AY Comparison

Compare ARWR & AY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • AY
  • Stock Information
  • Founded
  • ARWR 2003
  • AY 2013
  • Country
  • ARWR United States
  • AY United Kingdom
  • Employees
  • ARWR 525
  • AY N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • AY Electric Utilities: Central
  • Sector
  • ARWR Health Care
  • AY Utilities
  • Exchange
  • ARWR Nasdaq
  • AY Nasdaq
  • Market Cap
  • ARWR 2.7B
  • AY 2.6B
  • IPO Year
  • ARWR 1993
  • AY 2014
  • Fundamental
  • Price
  • ARWR $22.04
  • AY $21.99
  • Analyst Decision
  • ARWR Buy
  • AY Buy
  • Analyst Count
  • ARWR 12
  • AY 6
  • Target Price
  • ARWR $42.70
  • AY $21.80
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • AY 1.1M
  • Earning Date
  • ARWR 02-04-2025
  • AY 11-14-2024
  • Dividend Yield
  • ARWR N/A
  • AY 7.08%
  • EPS Growth
  • ARWR N/A
  • AY N/A
  • EPS
  • ARWR N/A
  • AY 0.25
  • Revenue
  • ARWR $3,551,000.00
  • AY $1,190,319,000.00
  • Revenue This Year
  • ARWR $4,225.26
  • AY $5.84
  • Revenue Next Year
  • ARWR $59.48
  • AY $6.55
  • P/E Ratio
  • ARWR N/A
  • AY $87.89
  • Revenue Growth
  • ARWR N/A
  • AY 7.99
  • 52 Week Low
  • ARWR $17.05
  • AY $16.82
  • 52 Week High
  • ARWR $39.83
  • AY $23.47
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.44
  • AY 0.41
  • Support Level
  • ARWR $21.48
  • AY $21.92
  • Resistance Level
  • ARWR $22.47
  • AY $22.17
  • Average True Range (ATR)
  • ARWR 1.27
  • AY 0.02
  • MACD
  • ARWR -0.23
  • AY -2.21
  • Stochastic Oscillator
  • ARWR 12.63
  • AY 0.00

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About AY Atlantica Sustainable Infrastructure plc

Atlantica Sustainable Infrastructure PLC owns, manages, and acquires renewable energy, conventional power, electric transmission lines and water assets. It is focused on North America (the United States and Mexico), South America (Peru, Chile, Brazil, and Uruguay) and EMEA (Spain, Algeria and South Africa). The company's segments include North America, South America and Europe, Middle East and Africa. The renewable energy sector includes the company's activities related to the production of electricity from solar power and wind plants. Atlantica derives the majority of its revenues from EMEA, followed by South America and North America.

Share on Social Networks: